Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "IFF"

1680 News Found

Differentiation based on innovation is the way forward: S Aparna
News | April 26, 2022

Differentiation based on innovation is the way forward: S Aparna

Secretary, Department of Pharmaceuticals and Union Health Secretary Chair a Panel Discussion on the theme 'Indian Pharma Vision 2047'


Roche introduces molecular testing solutions to differentiate Covid-19 variants
Medical Device | March 17, 2022

Roche introduces molecular testing solutions to differentiate Covid-19 variants

Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and Delta


IFF to acquire contract manufacturer of dietary supplements Health Wright Products
News | February 22, 2022

IFF to acquire contract manufacturer of dietary supplements Health Wright Products

The sale is expected to close in the first quarter of 2022


Skye Air Mobility to deploy drones to enhance Redcliffe Labs services
Clinical Trials | February 10, 2022

Skye Air Mobility to deploy drones to enhance Redcliffe Labs services

Urban, semi-urban and remote corners of the country will be catered using drone delivery technology


Redcliffe Labs appoints Abhay Singavi as Chief Business Officer
People | February 07, 2022

Redcliffe Labs appoints Abhay Singavi as Chief Business Officer

Takes charge to lead business innovation, strategy, alliance & partnerships


Green chemistry approaches to synthesis could make a big difference to pharma product outputs
News | January 20, 2022

Green chemistry approaches to synthesis could make a big difference to pharma product outputs

Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies


Redcliffe Labs chalks out aggressive expansion plans
Clinical Trials | December 08, 2021

Redcliffe Labs chalks out aggressive expansion plans

It plans to add over 1000 employees over the next six months


Antengene and MindRank AI to advance the development of difficult-to-drug molecular targets
Drug Approval | August 09, 2021

Antengene and MindRank AI to advance the development of difficult-to-drug molecular targets

Both companies aim to improve the efficiency and success rate of the current drug discovery process.


Kalahandi gets a major healthcare boost as Vedanta launches 24x7 telemed service
Healthcare | May 08, 2026

Kalahandi gets a major healthcare boost as Vedanta launches 24x7 telemed service

Initiative launched with Tata 1mg to benefit 70,000 people across 70 remote villages in Kalahandi region


Cirena licenses Agilent RNA purification tech to unlock high-purity long RNA for genome editing
Technology | May 08, 2026

Cirena licenses Agilent RNA purification tech to unlock high-purity long RNA for genome editing

The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides